M K Proteins shareholders adopt FY26 financials at 14th AGM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • M K Proteins held its 14th AGM on September 30, 2026, via video conferencing
  • Shareholders adopted audited financial statements for FY26
  • Raj Kumar was re-appointed as Director retiring by rotation
  • Aritika Garg appointed as Independent Director for a five-year term
  • Material transactions with related parties Kamla Oleo and Kamla Oils approved
powered bylight_fuzz_icon
52299019

*this image is generated using AI for illustrative purposes only.

M K Proteins shareholders adopted the audited financial statements for FY26 during the company's 14th Annual General Meeting held on September 30, 2026. The meeting, conducted through video conferencing, also saw the approval of key governance resolutions including director reappointments and related party transactions.

The proceedings were chaired by Parmod Kumar, Managing Director. The requisite quorum was present, allowing the meeting to commence at 11:05 am. Neha Aggarwal, Company Secretary and Compliance Officer, provided instructions to members participating virtually and confirmed that the Annual Report had been distributed electronically or via physical letters with web links.

Voting and Compliance Procedures

In compliance with Section 108 of the Companies Act, 2013, and SEBI (LODR) Regulations, 2015, the company facilitated remote e-voting from September 27 to September 29, 2026. Members who did not vote remotely were able to cast their votes electronically during the meeting. Jai Prakash Jagdev, a practicing company secretary, served as the scrutinizer for the voting process.

Key Resolutions Passed

Shareholders transacted several items of business, categorized into ordinary and special business. The resolutions covered the adoption of financial statements, director appointments, and approvals for material transactions with related parties.

Item Resolution Description Type
1 Adoption of Financial Statements for year ended March 31, 2026 Ordinary
2 Re-appointment of Raj Kumar, Director (DIN: 00126983) Ordinary
3 Ratification of remuneration for Cost Auditors for FY27 Ordinary
4 Appointment of Aritika Garg (DIN: 11895058) as Independent Director Special
5 Approval of material transactions with Kamla Oleo Private Limited Ordinary
6 Approval of material transactions with Kamla Oils and Fats Private Limited Ordinary

The meeting concluded at 11:38 am with a vote of thanks. Results of the e-voting, aggregated with remote voting results, are scheduled to be announced within the prescribed time period and made available on the company's website and stock exchange platforms.

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.30%-0.50%-2.91%-9.68%-41.03%+16.23%

How will the appointment of Aritika Garg as an Independent Director influence M K Proteins' corporate governance standards and strategic oversight in FY27?

What are the projected financial impacts of the approved material transactions with Kamla Oleo and Kamla Oils and Fats Private Limited on the company's future margins?

In what ways might the newly adopted financial statements for FY26 shape investor sentiment and stock valuation ahead of the next quarterly earnings report?

M K Proteins closes trading window ahead of Q2FY27 results declaration

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours post-Q2FY27 results declaration
  • Applies to all insiders including directors and promoters
  • Filed under SEBI (Prohibition of Insider Trading) Regulations, 2015
powered bylight_fuzz_icon
52138373

*this image is generated using AI for illustrative purposes only.

M K Proteins Limited has closed its trading window for transactions in its shares starting October 1, 2026. The closure remains in effect until the end of 48 hours after the declaration of un-audited financial results for the second quarter and half-year ended September 30, 2026.

This move is pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading. The restriction applies to employees, directors, key managerial personnel, promoters, designated persons, their immediate relatives, and any other insiders.

Regulatory Compliance Details

The company filed an intimation with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on September 28, 2026. The filing confirms that no insider transactions are permitted during this blackout period to prevent potential misuse of unpublished price-sensitive information.

Board Meeting Schedule

The specific date for the Board Meeting to consider the un-audited financial results for Q2FY27 and H1FY27 will be intimated in due course. Until then, the trading window remains strictly closed as per regulatory norms.

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.30%-0.50%-2.91%-9.68%-41.03%+16.23%

How might the upcoming Q2FY27 financial results influence MK Proteins' stock volatility once the trading window reopens?

What are the projected impacts of recent aquaculture feed price fluctuations on MK Proteins' half-year margins?

Will the company announce any strategic capacity expansion plans alongside its Q2 earnings release?

More News on MK Proteins

1 Year Returns:-41.03%